These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 362596)
1. [Recombinant DNA studies, a controversial subject which is also promising from the point of view of veterinary medicine (author's transl)]. Guinée PA; Van Embden J Tijdschr Diergeneeskd; 1978 Nov; 103(22):1207-16. PubMed ID: 362596 [TBL] [Abstract][Full Text] [Related]
2. [Successes and prospects for genetic engineering]. Alikhanian SI Genetika; 1976; 12(7):150-73. PubMed ID: 63407 [TBL] [Abstract][Full Text] [Related]
3. [Recombinant DNA and genetic manipulation, reality and fantasy (author's transl)]. Winkler KC Tijdschr Diergeneeskd; 1982 Jan; 107(1):4-11. PubMed ID: 6275569 [TBL] [Abstract][Full Text] [Related]
5. Spread of organisms with novel genotypes: thoughts from an ecological perspective. Sharples FE Recomb DNA Tech Bull; 1983 Jun; 6(2):43-56. PubMed ID: 6576449 [TBL] [Abstract][Full Text] [Related]
6. Ethical and social aspects of experimental gene manipulation. Roblin R Fed Proc; 1975 May; 34(6):1421-4. PubMed ID: 1092560 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of naked DNA uptake and expression. Wolff JA; Budker V Adv Genet; 2005; 54():3-20. PubMed ID: 16096005 [TBL] [Abstract][Full Text] [Related]
8. [Expression of eukaryotic genes in Escherichia coli cells]. Danilevskaia ON Genetika; 1979 Dec; 15(12):2087-107. PubMed ID: 389736 [TBL] [Abstract][Full Text] [Related]
9. [Genetic technology in the service of veterinary medicine. II. Basic research as primary beneficiary]. Hübscher U Schweiz Arch Tierheilkd; 1982 Nov; 124(11):567-76. PubMed ID: 6129698 [No Abstract] [Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
13. [Genetic surgery: results of a new technique (author's transl)]. Hobom G Arzneimittelforschung; 1977 Jan; 27(1B):182-5. PubMed ID: 322675 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of a model promoter for gene expression in Escherichia coli. Dobrynin VN; Korobko VG; Severtsova IV; Bystrov NS; Chuvpilo SA; Kolosov MN Nucleic Acids Symp Ser; 1980; (7):365-76. PubMed ID: 6265875 [TBL] [Abstract][Full Text] [Related]
15. [Use of radioisotopes in recombinant DNA research]. Takagi Y Radioisotopes; 1984 Feb; 33(2):91-9. PubMed ID: 6330794 [No Abstract] [Full Text] [Related]
16. [In vitro construction of recombinant DNA molecules: a new development in genetics (author's transl)]. De Groot B Tijdschr Diergeneeskd; 1976 Dec; 101(24):1364-70. PubMed ID: 1070183 [No Abstract] [Full Text] [Related]
17. [Escherichia coli in biotechnology]. Hauptmann R; Falkner E Wien Med Wochenschr; 1986 Apr; 136(7-8):158-62. PubMed ID: 3524021 [TBL] [Abstract][Full Text] [Related]
18. [Localization of the genes coding for the specific modification-restriction system in the E. coli tF strain]. Popovski B Vet Med Nauki; 1987; 24(8):9-12. PubMed ID: 2830710 [TBL] [Abstract][Full Text] [Related]
19. The impact of phage lambda: from restriction to recombineering. Murray NE Biochem Soc Trans; 2006 Apr; 34(Pt 2):203-7. PubMed ID: 16545077 [TBL] [Abstract][Full Text] [Related]
20. [The present state of the recombinant DNA research in U.S.A. ((author's transl)]. Oshima Y Tanpakushitsu Kakusan Koso; 1977 May; 22(5):323-38. PubMed ID: 407627 [No Abstract] [Full Text] [Related] [Next] [New Search]